Petco Health and Wellness Company (WOOF) Ratios
Petco Health and Wellness Company Ratios
MX:WOOF's free cash flow for Q2 2026 was $129.92M. For the 2026 fiscal year, MX:WOOF's free cash flow was decreased by $-31.64M and operating cash flow was $161.55M. See a summary of the company’s cash flow.
| Ratios | Jan 26 | Jan 25 | Jan 24 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.90 | 0.85 | 0.86 | 0.99 | 1.02 |
| Quick Ratio | 0.38 | 0.28 | 0.24 | 0.36 | 0.38 |
| Cash Ratio | 0.23 | 0.15 | 0.11 | 0.20 | 0.20 |
| Solvency Ratio | 0.05 | 0.02 | -0.26 | 0.07 | 0.08 |
| Operating Cash Flow Ratio | 0.28 | 0.16 | 0.19 | 0.34 | 0.34 |
| Short-Term Operating Cash Flow Coverage | 0.97 | 7.62 | 13.51 | 15.18 | 16.46 |
| Net Current Asset Value | $ -2.99B | $ -3.11B | $ -3.23B | $ -3.22B | $ -3.17B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.55 | 0.57 | 0.57 | 0.47 | 0.47 |
| Debt-to-Equity Ratio | 2.46 | 2.66 | 2.57 | 1.32 | 1.34 |
| Debt-to-Capital Ratio | 0.71 | 0.73 | 0.72 | 0.57 | 0.57 |
| Long-Term Debt-to-Capital Ratio | 0.56 | 0.59 | 0.57 | 0.41 | 0.42 |
| Financial Leverage Ratio | 4.44 | 4.66 | 4.53 | 2.78 | 2.86 |
| Debt Service Coverage Ratio | 0.74 | 1.34 | -5.66 | 2.99 | 4.02 |
| Interest Coverage Ratio | 0.92 | 0.05 | -7.82 | 2.22 | 3.44 |
| Debt to Market Cap | 2.41 | 1.71 | 2.40 | 0.53 | 0.34 |
| Interest Debt Per Share | 10.70 | 11.35 | 11.94 | 12.18 | 11.79 |
| Net Debt to EBITDA | 7.59 | 12.97 | -3.00 | 7.19 | 6.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.67% | 38.00% | 37.63% | 40.21% | 41.79% |
| EBIT Margin | 2.46% | 0.25% | -18.75% | 3.54% | 4.82% |
| EBITDA Margin | 5.76% | 3.52% | -15.54% | 6.76% | 7.79% |
| Operating Profit Margin | 2.02% | 0.12% | -18.87% | 3.74% | 4.58% |
| Pretax Profit Margin | 0.26% | -1.79% | -20.91% | 2.08% | 3.67% |
| Net Profit Margin | 0.15% | -1.66% | -20.47% | 1.50% | 2.83% |
| Continuous Operations Profit Margin | 0.15% | -1.66% | -20.47% | 1.49% | 2.75% |
| Net Income Per EBT | 59.13% | 93.16% | 97.89% | 72.49% | 77.09% |
| EBT Per EBIT | 12.73% | -1550.09% | 110.80% | 55.53% | 80.16% |
| Return on Assets (ROA) | 0.18% | -1.96% | -23.87% | 1.37% | 2.53% |
| Return on Equity (ROE) | 0.78% | -9.14% | -108.09% | 3.81% | 7.23% |
| Return on Capital Employed (ROCE) | 2.98% | 0.17% | -27.77% | 4.03% | 4.89% |
| Return on Invested Capital (ROIC) | 1.63% | 0.15% | -25.16% | 2.73% | 3.48% |
| Return on Tangible Assets | 0.29% | -3.19% | -38.13% | 2.68% | 5.00% |
| Earnings Yield | 1.21% | -10.89% | -192.94% | 2.91% | 3.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 130.13 | 151.30 | 140.98 | 121.74 | 104.41 |
| Payables Turnover | 8.12 | 7.69 | 8.04 | 9.47 | 8.37 |
| Inventory Turnover | 6.20 | 5.80 | 5.70 | 5.53 | 5.01 |
| Fixed Asset Turnover | 3.07 | 3.02 | 2.84 | 2.74 | 2.81 |
| Asset Turnover | 1.15 | 1.18 | 1.17 | 0.91 | 0.89 |
| Working Capital Turnover Ratio | -42.60 | -37.42 | -75.07 | 975.59 | -144.96 |
| Cash Conversion Cycle | 16.75 | 17.86 | 21.24 | 30.43 | 32.77 |
| Days of Sales Outstanding | 2.80 | 2.41 | 2.59 | 3.00 | 3.50 |
| Days of Inventory Outstanding | 58.92 | 62.89 | 64.04 | 65.99 | 72.89 |
| Days of Payables Outstanding | 44.98 | 47.44 | 45.39 | 38.56 | 43.62 |
| Operating Cycle | 61.72 | 65.30 | 66.63 | 68.98 | 76.39 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.12 | 0.65 | 0.81 | 1.30 | 1.35 |
| Free Cash Flow Per Share | 0.67 | 0.18 | -0.04 | 0.26 | 0.45 |
| Dividend Paid and CapEx Coverage Ratio | 2.47 | 1.39 | 0.96 | 1.24 | 1.50 |
| Capital Expenditure Coverage Ratio | 2.47 | 1.39 | 0.96 | 1.24 | 1.50 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.06 | 0.07 | 0.11 | 0.12 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.03 | 0.03 | 0.06 | 0.06 |
| Free Cash Flow Yield | 24.86% | 5.31% | -1.49% | 2.18% | 2.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 83.02 | -9.24 | -0.52 | 34.33 | 29.52 |
| Price-to-Sales (P/S) Ratio | 0.13 | 0.15 | 0.11 | 0.52 | 0.84 |
| Price-to-Book (P/B) Ratio | 0.65 | 0.84 | 0.56 | 1.31 | 2.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.02 | 18.82 | -67.16 | 45.85 | 40.75 |
| Price-to-Operating Cash Flow Ratio | 2.39 | 5.26 | 3.08 | 9.01 | 13.55 |
| Price-to-Earnings Growth (PEG) Ratio | -0.76 | 0.10 | 0.00 | -0.76 | -0.05 |
| Enterprise Value Multiple | 9.78 | 17.32 | -3.69 | 14.83 | 17.01 |
| Enterprise Value | 3.36B | 3.73B | 3.58B | 6.05B | 7.69B |
| EV to EBITDA | 9.78 | 17.32 | -3.69 | 14.83 | 17.01 |
| EV to Sales | 0.56 | 0.61 | 0.57 | 1.00 | 1.32 |
| EV to Free Cash Flow | 17.95 | 75.04 | -362.54 | 88.96 | 64.57 |
| EV to Operating Cash Flow | 10.69 | 20.98 | 16.60 | 17.48 | 21.47 |
| Tangible Book Value Per Share | -3.01 | -3.26 | -3.07 | -3.15 | -3.59 |
| Shareholders’ Equity Per Share | 4.16 | 4.07 | 4.43 | 8.97 | 8.58 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.41 | 0.07 | 0.02 | 0.28 | 0.25 |
| Revenue Per Share | 21.32 | 22.37 | 23.38 | 22.73 | 21.90 |
| Net Income Per Share | 0.03 | -0.37 | -4.78 | 0.34 | 0.62 |
| Tax Burden | 0.59 | 0.93 | 0.98 | 0.72 | 0.77 |
| Interest Burden | 0.10 | -7.02 | 1.12 | 0.59 | 0.76 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.37 | 0.38 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 34.64 | -1.75 | -0.17 | 3.85 | 2.24 |
Currency in USD
